(2S,5S)-5-Methylpyrrolidine-2-carboxylic acid hydrochloride, 98%, 1g

tert-Butyl 4-amino-4-(aminomethyl)piperidine-1-carboxylate, 95.0%, 250mg

1-(2-thienylmethyl)-1,4-diazepane dihydrochloride, 95.0%, 1g

Filler/venting cap, 83 B, 6,3 mm, 1 Piece

4-Chloro-5-fluoropyridine-3-carboxylic Acid, 98+%, 1g

Methyl 2-(bromomethyl)-5-methoxybenzoate, 95.0%, 5g

N,N,N',N'-Ethylenediaminetetrakis(methylenephosphonic Acid)>95.0%(T)100g

(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol, 97%, 1g

1-tert-Butyl 3-Ethyl 4-Oxopyrrolidine-1,3-dicarboxylate>97.0%(HPLC)(N)1g

1-(4-bromophenyl)-2-(3-nitro-1H-pyrazol-1-yl)ethan-1-one, 95.0%, 1g

[4-(Adamantan-1-yl)phenyl]boronic acid, 97%, 5g

2-(4-Chlorophenoxy)-5-nitropyridine, 97.0%, 5g

1-(3,5-Dimethylphenyl)cyclopropanamine hydrochloride, 100mg